Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2012 3
2013 6
2014 1
2015 1
2017 1
2018 1
2019 4
2020 3
2022 2
2023 4
2024 2
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
High-risk abdominal pediatric paraganglioma.
Poumeaud F, Duval M, Gambart M, O Dierickx L, Abbo O, Hangard G, Doyen J, Vidal M, Aubert S, Carillo F, Mouly C, Vial J, Gomez-Brouchet A, Laprie A. Poumeaud F, et al. Among authors: mouly c. Pediatr Blood Cancer. 2023 Jan;70(1):e29834. doi: 10.1002/pbc.29834. Epub 2022 Aug 15. Pediatr Blood Cancer. 2023. PMID: 35731232 No abstract available.
BRAF and MEK inhibitor targeted therapy in papillary craniopharyngiomas: a cohort study.
De Alcubierre D, Gkasdaris G, Mordrel M, Joncour A, Briet C, Almairac F, Boetto J, Mouly C, Larrieu-Ciron D, Vasiljevic A, Villa C, Sergeant C, Ducray F, Feuvret L, Chanson P, Baussart B, Raverot G, Jouanneau E. De Alcubierre D, et al. Among authors: mouly c. Eur J Endocrinol. 2024 Aug 5;191(2):251-261. doi: 10.1093/ejendo/lvae091. Eur J Endocrinol. 2024. PMID: 39158090
Surgery for the treatment of arterial hypertension in patients with unilateral adrenal incidentalomas and mild autonomous cortisol secretion (CHIRACIC): a multicentre, open-label, superiority randomised controlled trial.
Tabarin A, Espiard S, Deutschbein T, Amar L, Vezzossi D, Di Dalmazi G, Reznik Y, Young J, Desailloud R, Goichot B, Drui D, Assié G, Lefebvre H, Mai K, Castinetti F, Laboureau S, Terzolo M, Ferriere A, Georget A, Frison E, Vantyghem MC, Fassnacht M, Gosse P; CHIRACIC Collaborators. Tabarin A, et al. Lancet Diabetes Endocrinol. 2025 Jul;13(7):580-590. doi: 10.1016/S2213-8587(25)00062-2. Epub 2025 May 12. Lancet Diabetes Endocrinol. 2025. PMID: 40373786 Clinical Trial.
Beyond MEN1, When to Think About MEN4? Retrospective Study on 5600 Patients in the French Population and Literature Review.
Chevalier B, Coppin L, Romanet P, Cuny T, Maïza JC, Abeillon J, Forestier J, Walter T, Gilly O, Le Bras M, Smati S, Nunes ML, Geslot A, Grunenwald S, Mouly C, Arnault G, Wagner K, Koumakis E, Cortet-Rudelli C, Merlen É, Jannin A, Espiard S, Morange I, Baudin É, Cavaille M, Tauveron I, Teissier MP, Borson-Chazot F, Mirebeau-Prunier D, Savagner F, Pasmant É, Giraud S, Vantyghem MC, Goudet P, Barlier A, Cardot-Bauters C, Odou MF. Chevalier B, et al. Among authors: mouly c. J Clin Endocrinol Metab. 2024 Jun 17;109(7):e1482-e1493. doi: 10.1210/clinem/dgae055. J Clin Endocrinol Metab. 2024. PMID: 38288531 Review.
26 results